Zobrazeno 1 - 8
of 8
pro vyhledávání: '"бетаметазона дипропионат"'
Autor:
I. E. Torshina
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 0, Iss 5, Pp 102-108 (2017)
The article presents the current literature data on the rationale for the inclusion in complex therapy (combined corticosteroid drugs) for patients with steroid-sensitive dermatoses complicated by secondary infection. This article contains informatio
Externí odkaz:
https://doaj.org/article/f0bf2a0b3ca74aa59e6bafcbc60a297c
Autor:
V. A. Okhlopkov, E. YU. Zubareva, YU. A. Novikov, M. S. Sukach, T. V. Repina, I. YU. Lekavitchus, N. V. Grankina
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 0, Iss 3, Pp 121-127 (2017)
The results of direct open-label study of efficacy and portability of combination therapy with topical betamethasone dipropionate and mupirocin are presented. Material and methods. Twenty two patients with pyoderma complicated eczema were treated wit
Externí odkaz:
https://doaj.org/article/932ad182b8494509bc837d0608ed1a04
Autor:
N. N. Filimonkova, YE. A. Bakhlykova!
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 0, Iss 3, Pp 147-152 (2017)
The article analyzes literature sources on the etticacy ot the topical glucocorticosteroid therapy ot chronic dermatoses. Special attention is paid to evidence-based studies ot the etticacy and satety ot a combination therapy ot complicated chronic d
Externí odkaz:
https://doaj.org/article/b1d88657b2d84416948b3d2b574d54dd
Autor:
I. E. Torshina
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 0, Iss 5, Pp 102-108 (2017)
The article presents the current literature data on the rationale for the inclusion in complex therapy (combined corticosteroid drugs) for patients with steroid-sensitive dermatoses complicated by secondary infection. This article contains informatio
Autor:
N. N. Filimonkova, Ye. A. Bakhlykova
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 0, Iss 3, Pp 147-152 (2017)
The article analyzes literature sources on the etticacy ot the topical glucocorticosteroid therapy ot chronic dermatoses. Special attention is paid to evidence-based studies ot the etticacy and satety ot a combination therapy ot complicated chronic d
Publikováno v:
Актуальні питання фармацевтичної та медичної науки та практики; № 2 (2017)
Current issues in pharmacy and medicine: science and practice; № 2 (2017)
Актуальные вопросы фармацевтической и медицинской науки и практики; № 2 (2017)
Current issues in pharmacy and medicine: science and practice; № 2 (2017)
Актуальные вопросы фармацевтической и медицинской науки и практики; № 2 (2017)
The range of combined domestic drug products in suspension for injections form with a specific purpose for the topical treatment of rheumatoid arthritis is limited, and available drug products are mainly submitted by foreign companies and their numbe
Publikováno v:
Clinical pharmacy; Vol. 20 No. 4 (2016); 30-34
Клиническая фармация; Том 20 № 4 (2016); 30-34
Клінічна фармація; Том 20 № 4 (2016); 30-34
Клінічна фармація; Том 20, № 4 (2016): Клінічна фармація; 30-34
Klìnìčna farmacìâ; Том 20, № 4 (2016): Klìnìčna farmacìâ; 30-34
Клиническая фармация; Том 20, № 4 (2016): Клиническая фармация; 30-34
Клиническая фармация; Том 20 № 4 (2016); 30-34
Клінічна фармація; Том 20 № 4 (2016); 30-34
Клінічна фармація; Том 20, № 4 (2016): Клінічна фармація; 30-34
Klìnìčna farmacìâ; Том 20, № 4 (2016): Klìnìčna farmacìâ; 30-34
Клиническая фармация; Том 20, № 4 (2016): Клиническая фармация; 30-34
In spite of a great number of the existing drugs and methods, as well as introduction of the new ones, the problem of improving the treatment of patients with psoriasis and psoriatic arthritis is still one of the most burning and topical in modern de
Publikováno v:
Саратовский научно-медицинский журнал.
У больных микробной экземой с помощью клинических и микробиологических исследований показано, что применение топического комбинирова